Detalhe da pesquisa
1.
C-type natriuretic peptide is a pivotal regulator of metabolic homeostasis.
Proc Natl Acad Sci U S A
; 119(13): e2116470119, 2022 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35333648
2.
A comparison of the chemical biology of hydropersulfides (RSSH) with other protective biological antioxidants and nucleophiles.
Nitric Oxide
; 107: 46-57, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253886
3.
Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure.
Proc Natl Acad Sci U S A
; 115(31): E7428-E7437, 2018 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30012589
4.
C-type natriuretic peptide co-ordinates cardiac structure and function.
Eur Heart J
; 41(9): 1006-1020, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30903134
5.
Endothelial C-Type Natriuretic Peptide Is a Critical Regulator of Angiogenesis and Vascular Remodeling.
Circulation
; 139(13): 1612-1628, 2019 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586761
6.
The biological impact of blood pressure-associated genetic variants in the natriuretic peptide receptor C gene on human vascular smooth muscle.
Hum Mol Genet
; 27(1): 199-210, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29040610
7.
Multiplicity of Nitric Oxide and Natriuretic Peptide Signaling in Heart Failure.
J Cardiovasc Pharmacol
; 75(5): 370-384, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31498237
8.
C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature.
Int J Mol Sci
; 20(9)2019 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31072047
9.
IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD.
J Am Soc Nephrol
; 28(1): 94-105, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27153924
10.
Raised arterial blood pressure in neurokinin-1 receptor-deficient mice (NK1R(-/-) ): evidence for a neural rather than a vascular mechanism.
Exp Physiol
; 101(5): 588-98, 2016 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26876733
11.
Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.
Circulation
; 130(6): 496-507, 2014 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24899690
12.
C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling.
Circ Res
; 112(10): 1355-64, 2013 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23529183
13.
Controlled release of C-type natriuretic peptide by microencapsulation dampens proinflammatory effects induced by IL-1ß in cartilage explants.
Biomacromolecules
; 16(2): 524-31, 2015 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556565
14.
Endothelial injury in a transforming growth factor ß-dependent mouse model of scleroderma induces pulmonary arterial hypertension.
Arthritis Rheum
; 65(11): 2928-39, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23839959
15.
NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension.
JCI Insight
; 9(10)2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652537
16.
Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase.
Circulation
; 125(23): 2922-32, 2012 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22572914
17.
A Janus-Faced Role for Atrial Natriuretic Peptide in Myocardial Infarction?
Circ Res
; 119(2): 181-3, 2016 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27390327
18.
LXRα regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8.
Circ Res
; 109(5): 492-501, 2011 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21757649
19.
Vasoactive peptides and the pathogenesis of pulmonary hypertension: role and potential therapeutic application.
Handb Exp Pharmacol
; 218: 477-511, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24092352
20.
Novel enhancers of guanylyl cyclase-A activity acting via allosteric modulation.
Br J Pharmacol
; 180(24): 3254-3270, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37522273